Brain scan and blood test study aims to predict stroke recovery

NCT ID NCT07611136

First seen May 28, 2026

Summary

This study follows 180 adults with cerebral small vessel disease to see how their condition changes over time after a stroke. Researchers will use MRI scans and blood tests to track disease progression and look for links to thinking skills, daily function, and stroke recurrence. The goal is to better understand the disease and find new ways to monitor it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospital Ulm, Department of Neurology, Germany

    RECRUITING

    Ulm, Baden-Wurttemberg, 89081, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better predict how small vessel disease progresses after a stroke, potentially guiding future treatments.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly improve health. Results may not apply to all patients, and biomarkers may not reliably predict disease course.

Conditions

The condition(s) this trial relates to.

Cerebral Small Vessel Diseases stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.